Cargando…
Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality
The risk of premature death is high among patients on haemodialysis (HD patients). We previously determined that immunoglobulin (Ig)M antibodies against phosphorylcholine (anti‐PC) are negatively associated with increased risk of cardiovascular disease (CVD), atherosclerosis, some autoimmune disease...
Autores principales: | Samal, S. K., Qureshi, A. R., Rahman, M., Stenvinkel, P., Frostegård, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290086/ https://www.ncbi.nlm.nih.gov/pubmed/32297318 http://dx.doi.org/10.1111/cei.13441 |
Ejemplares similares
-
Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes
por: Samal, Shailesh Kumar, et al.
Publicado: (2020) -
Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
por: Frostegård, Johan
Publicado: (2023) -
Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases
por: de Vries, M. R., et al.
Publicado: (2021) -
Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions
por: Samal, Shailesh Kumar, et al.
Publicado: (2022) -
Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014)